Skip to main content

New survey data from the U.S. Centers for Disease Control and Prevention show that Americans have experienced long COVID at an estimated rate of nearly 7%, with an estimated 3.5% reporting long COVID at the time of the survey interview, conducted in 2022. But rates weren't equal across the board: Women, adults ages 35-49, individuals of Hispanic origin, and those living in non-metropolitan areas were more likely to have had the condition.

The numbers, presented in a data brief from the CDC's National Center for Health Statistics, or NCHS, are based on responses from 27,651 community-dwelling adults who participated in the 2022 National Health Interview Survey, a nationally representative household survey. Participants who reported ever receiving a positive COVID-19 test or a physician's diagnosis were asked if they had any symptoms that lasted three months or longer, and whether those symptoms were present at the time of interview.

Among the findings:

  • Overall, 6.9% of respondents said that they had experienced long COVID, with 3.4% reporting current long COVID symptoms.
  • In both the group to ever report symptoms and the group with current symptoms, women were significantly more likely to report long COVID, with 8.5% of women saying that they had experienced the condition in the past compared with 5.2% of men, and 4.4% of women reporting current symptoms compared with 2.3% of men.
  • Adults ages 35-49 reported the highest incidence of long COVID (8.9%) compared with the 50-64 age group (7.6) and the 18-34 age group (6.9%). Adults 65 and older reported the lowest rates of ever having had long COVID, at 4.1%.
  • Hispanic adults reported the highest incidence of ever having had long COVID (8.3%) compared with white non-Hispanic (7.1%), Black non-Hispanic (5.4%), and Asian non-Hispanic (2.6%) respondents. Among adults reporting current symptoms, Hispanic and white non-Hispanic adults reported roughly equal rates (3.4% and 3.7% respectively), while Asian non-Hispanic adults reported the lowest rate (1.1%). Black non-Hispanic respondents reported current symptoms at a rate of 2.4%.
  • Based on the center's rural-urban classifications, adults in non-metropolitan areas reported the highest rates of "ever" (7.7%) and currently (4.1%) having long COVID, followed closely by adults living in medium and small metropolitan areas (7.6% ever, 3.9% current). Residents of large central metropolitan areas reported the lowest rates of long COVID, with 6.3% reporting ever having symptoms and 2.6% reporting current symptoms.

APTA offers multiple opportunities for members and the public to better understand the role of physical therapy in the treatment of long COVID, including a clinical summary, links to provider and patient resources, a collection of relevant research, and more. Consumers can learn more about the condition — and how PTs and PTAs can help — by visiting ChoosePT.com, APTA's consumer-facing website, which houses a collection of COVID-19 and long COVID content aimed at consumers. ChoosePT content includes educational resources, personal accounts of individuals experiencing long COVID, and links to ChoosePT.com's Find a PT tool that helps connect consumers with a PT in their area. If you focus on treating individuals with long COVID in your clinic, make sure to update your Find a PT profile and select COVID-19/Long COVID as a practice focus so consumers seeking a physical therapist familiar with treating its effects can find you.


You Might Also Like...

Review

From PTJ: Functional and Aerobic Exercises Can Aid Long COVID Recovery

Jan 23, 2024

Researchers also found that telerehab may be ‘an optimal intervention’ for physical therapy patients with long COVID.

Roundup

Coronavirus and Long COVID Update, October 2023

Oct 23, 2023

SSRIs and Long COVID, Post-COVID-19 organ abnormalities, lingering symptoms among children, and more.

Roundup

Coronavirus Update: May 17

May 17, 2023

The pandemic's effect on the physical therapy profession, the post-PHE provider landscape, exercise effects on lingering symptoms, and more.